Cardiology (all articles)
Meta-analysis: Overall and cause-specific mortality in randomized clinical trials comparing percutaneous interventions with coronary bypass surgery
14 Oct, 2020 | 09:16h | UTCOverall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis – JAMA Internal Medicine (free for a limited period)
Commentary on Twitter
In an analysis of 23 randomized trials comparing CABG and PCI, PCI was associated with higher rates of cardiac, non-cardiac, and all-cause mortality. All-cause mortality should be used as endpoint in revascularization trials https://t.co/DBSvVkr3EK
— JAMA Internal Medicine (@JAMAInternalMed) October 12, 2020
AHA Scientific Statement: Assessing and addressing cardiovascular health in LGBTQ adults
12 Oct, 2020 | 00:29h | UTCNews Release: Discrimination contributes to poorer heart health for LGBTQ adults – American Heart Association
Commentary: Improving the Cardiovascular Health of the LGBTQ Community: An Urgent Call to Action
Top Things to Know: Assessing and Addressing Cardiovascular Health in LGBTQ Adults
Meta-analysis: Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with Type 2 diabetes
8 Oct, 2020 | 08:57h | UTC
Expert analysis: Very low carbohydrate and ketogenic diets and cardiometabolic risk
8 Oct, 2020 | 08:58h | UTCVery Low Carbohydrate and Ketogenic Diets and Cardiometabolic Risk – American College of Cardiology
Long-term health consequences of COVID-19
6 Oct, 2020 | 00:58h | UTCLong-term Health Consequences of COVID-19 – JAMA
Commentary on Twitter
Persistent post-COVID symptoms could be the from direct tissue invasion by the virus, profound inflammation & cytokine storm, related immune system damage, hypercoagulable state, or some combination https://t.co/G8tI9U3TaL @CarlosdelRio7 lfcollins_md @PreetiNMalani
— JAMA (@JAMA_current) October 5, 2020
Cohort study: In-hospital cardiac arrest in critically ill patients with Covid-19
2 Oct, 2020 | 09:24h | UTCCommentary: Cardiac arrest, poor survival rates common in sickest patients with COVID-19 – University of Michigan
Related Study: Clinical Outcomes of In-Hospital Cardiac Arrest in COVID-19 – JAMA Internal Medicine
Commentaries on Twitter
Cardiac arrest with severe #COVID19, in-hospital:
relatively common, very poor outcome, especially w/ ⬆️age
Two series:
701 patients (14%)https://t.co/Pu0V15lemL @bmj_latest @salimhayek @umichmedicine @MHealthLab
60 patients (5%)https://t.co/Exwk68VXgg @JAMAInternalMed pic.twitter.com/9cwS0HlNxz— Eric Topol (@EricTopol) October 2, 2020
Cardiac arrest is common in critically ill patients with #COVID19 and is associated with poor survival, particularly among patients aged 80 or older, finds new research @salimhayek
https://t.co/O2Z2K3TAeT— The BMJ (@bmj_latest) October 1, 2020
Drug-related orthostatic hypotension: Beyond anti-hypertensive medications
2 Oct, 2020 | 09:13h | UTCDrug-Related Orthostatic Hypotension: Beyond Anti-Hypertensive Medications – Drugs & Aging
Commentary on Twitter
Drug-Related Orthostatic Hypotension: Beyond Anti-Hypertensive Medications. An open access review … https://t.co/YB0KiEiAtF pic.twitter.com/YzfsmQmtbZ
— Rohan Elliott (@elliott_rohan) September 30, 2020
Viewpoint: COVID-19 and heart failure with preserved ejection fraction
1 Oct, 2020 | 09:06h | UTCCOVID-19 and Heart Failure With Preserved Ejection Fraction – JAMA
AHA Scientific Statement: Cardiorenal protection with the newer antidiabetic agents in patients with diabetes and chronic kidney disease
29 Sep, 2020 | 10:00h | UTCNews Release: Newer Type 2 diabetes medications have heart and kidney disease benefits, too – AHA Newsroom
JAMA Network Series: Medical Specialties and the COVID-19 Pandemic
24 Sep, 2020 | 09:45h | UTCEditorial: The COVID-19 Pandemic and the JAMA Network
See articles:
- Cardiology and COVID-19
- Dermatology and COVID-19
- Internal Medicine and COVID-19
- Nephrology and COVID-19
- Neurology and COVID-19
- Oncology and COVID-19
- Ophthalmology and COVID-19
- Otolaryngology–Head and Neck Surgery and COVID-19
- Pediatrics and COVID-19
- Psychiatry and COVID-19
- Surgery and COVID-19
- JAMA Network Open and COVID-19
- JAMA Health Forum and COVID-19
COVID-19 can affect the heart
24 Sep, 2020 | 09:30h | UTCCOVID-19 can affect the heart – Science
Commentary on Twitter
"These complications, which at times are the only features of #COVID19 clinical presentation, have occurred even in cases with mild symptoms and in people who did not experience any symptoms" https://t.co/q42cY3ujV4
a 🧵to explain 1/— Eric Topol (@EricTopol) September 24, 2020
Meta-analysis: Central fatness and risk of all-cause mortality
24 Sep, 2020 | 09:19h | UTC
Commentary on Twitter
https://twitter.com/bmj_latest/status/1308909015867494400
Diagnostic test interpretation: Coronary computed tomography angiography
24 Sep, 2020 | 09:14h | UTCCoronary Computed Tomography Angiography – JAMA (free for a limited period)
Cardiac arrhythmias in critically ill patients with COVID-19: A brief review
22 Sep, 2020 | 09:59h | UTC
The core lesson of the COVID-19 heart debate
22 Sep, 2020 | 10:00h | UTCThe Core Lesson of the COVID-19 Heart Debate – The Atlantic
Commentary on Twitter
https://twitter.com/ChecchiaPaul/status/1308065655099478018
Guideline: Management of dyslipidemia for cardiovascular disease risk reduction
22 Sep, 2020 | 09:33h | UTCSummary: VA/DoD Guidelines on Dyslipidemia Recommend Against Frequent LDL Testing – NEJM Journal Watch
Commentary on Twitter
https://twitter.com/ATallantMD/status/1308199038513278978
Editorial: Two remedies for inappropriate percutaneous coronary intervention—closing the gap between evidence and practice
22 Sep, 2020 | 09:28h | UTCEditorial: Two Remedies for Inappropriate Percutaneous Coronary Intervention—Closing the Gap Between Evidence and Practice (free for a limited period)
Original Studies: Potential Association of the ISCHEMIA Trial With the Appropriate Use Criteria Ratings for Percutaneous Coronary Intervention in Stable Ischemic Heart Disease – JAMA Internal Medicine (free for a limited period) AND US False Claims Act Investigations of Unnecessary Percutaneous Coronary Interventions – JAMA Internal Medicine (free for a limited period)
Clinical update: Hormonal contraception in women with hypertension
22 Sep, 2020 | 09:32h | UTCHormonal Contraception in Women With Hypertension – JAMA (free for a limited period)
Commentary on Twitter
https://twitter.com/JAMA_current/status/1308088618846691330
A comprehensive update on aspirin management during noncardiac surgery
22 Sep, 2020 | 09:24h | UTCA Comprehensive Update on Aspirin Management During Noncardiac Surgery – Anesthesia & Analgesia
ESC Position Paper: Integration of a palliative approach into heart failure care
18 Sep, 2020 | 09:24h | UTC
Commentary on Twitter
Palliative care should be part of every #heartfailure management programme. Read about how you can discuss and implement it in #EJHF https://t.co/lpR3Jb1I9p@MarcoMetra @HFA_President @kevin_damman pic.twitter.com/tA9nCMHiyS
— European Society of Cardiology Journals (@ESC_Journals) September 17, 2020
Randomized trial: Opportunistic screening vs. usual care for detection of atrial fibrillation in primary care
17 Sep, 2020 | 09:21h | UTC
Commentary on Twitter
Opportunistic screening for atrial fibrillation in primary care patients, aged 65 and over, did not increase the detection rate of atrial fibrillation, finds this cluster randomised controlled trialhttps://t.co/PnjTZO9IKC
— The BMJ (@bmj_latest) September 16, 2020
Lifelong aspirin for all in the secondary prevention of chronic coronary syndrome: Still sacrosanct or is reappraisal warranted?
17 Sep, 2020 | 09:19h | UTCLifelong Aspirin for All in the Secondary Prevention of Chronic Coronary Syndrome: Still Sacrosanct or is Reappraisal Warranted? – Circulation (free for a limited period)
Multisystem effects of COVID-19: A concise review for practitioners
16 Sep, 2020 | 09:14h | UTCMultisystem effects of COVID-19: A concise review for practitioners – Postgraduate Medicine
Open letter calls on cardiovascular societies to discourage cardiac magnetic resonance after mild COVID-19
16 Sep, 2020 | 09:09h | UTCOpen Letter Calls on CV Societies to Discourage CMR After Mild COVID-19 – TCTMD
AHA Scientific Statement: Drug-induced arrhythmias
16 Sep, 2020 | 08:50h | UTCDrug-Induced Arrhythmias: A Scientific Statement From the American Heart Association – Circulation
Commentary: Drug Proarrhythmia
Top Things to Know: Drug-Induced Arrhythmias
News Release: Identifying, preventing and managing heart rhythm side effects of medicines